Search Articles
MANHATTAN – Hoping to represent a class of direct purchasers of propranolol, the generic version of the beta-blocker Inderal, FWK Holdings accuses 10 drugmakers of fixing prices. The defendants include Actavis Elizabeth, Teva Pharmaceuticals, Mylan, Par Pharmaceuticals and Heritage Pharmaceuticals.
Follow @bleonardcnsSubscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.